Pere G.
- Country
- Spain
- Department
- Hepatology
Research Overview
- Biomarker‑Guided Personalized Human Serum Albumin Therapy in Decompensated Cirrhosis with Ascites: A Multinational Randomized Controlled Trial
- ALB-TRIAL: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites
- Evaluation of Pegozafermin Efficacy and Safety in Patients with Metabolic Dysfunction-Associated Steatohepatitis and Fibrosis: A Phase 3 Clinical Trial
Data & Insights
Has run more than one trial at 8 of 90 partner sites.
Specializations
Hepatology
This investigator specializes in liver disease management, with particular emphasis on cirrhosis and its complications.
- Advanced liver disease treatment
- Cirrhotic complications management
- Ascites treatment approaches
The investigator focuses on developing personalized therapeutic strategies for patients with liver complications.
Therapeutic Innovation
The investigator's work centers on albumin-based therapies and their application in liver disease treatment.
- Personalized albumin administration
- Biomarker validation studies
- Treatment response prediction
Their research explores innovative approaches to optimizing therapeutic interventions in hepatology.
Clinical Assessment
The investigator specializes in predictive medicine within the context of liver disease treatment.
- Treatment response evaluation
- Biomarker assessment
- Patient outcome monitoring
Their work involves evaluating therapeutic effectiveness through biomarker analysis and patient response assessment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.